Vitreous
Producer: RUP of Belmedpreparata Republic of Belarus
Code of automatic telephone exchange: D03A
Release form: Liquid dosage forms. Solution for injections.
General characteristics. Structure:
Drug from a vitreous of eyes of the cattle.
Pharmacological properties:
Pharmacodynamics. Drug exerts the stimulating impact on formation of a bone callosity, reduces pain at damages of peripheral nerves. Softens cicatricial fabric and promotes its rassasyvaniye.
Indications to use:
Apply at nervous and physical overfatigue, the general breakdown, astenisation, nutritional and postinfectious dystrophy, neuritis, polyneurites, radiculitises, neuralgia, a stump neuralgia, to prevention of excess growth of connecting fabric in the early postoperative period, to a softening and a rassasyvaniye of cicatricial fabric, to treatment burn, postoperative, keloid and other origin of extensive hems, contractures of joints, at a keratitis, ulcers and burns of a cornea, to acceleration of formation of a bone callosity at changes.
Route of administration and doses:
The drug is administered under skin on 2 ml daily.
Course of treatment at neuralgia — 8 — 10 days, at hems, contractures and changes — up to 25 days.
Repetition of a course of treatment is recommended in one month or later.
Features of use:
With care appoint drug to patients with burdened allergoanamnezy.
Side effects:
Are not revealed.
Interaction with other medicines:
The negative phenomena at use of drug along with other medicines are noted.
Contraindications:
Infectious diseases, acute inflammatory processes, cachexia, nephrite, nephrosclerosis, cirrhosis, congestive heart failure with hypostases, malignant tumors.
Overdose:
So far the overdose phenomena at use of the drug "Vitreous" are not described.
Issue conditions:
According to the recipe
Packaging:
Solution for injections in ampoules of 2 ml in packaging No. 10.